TokenPost·
AstraZeneca Posts $16.21 Billion in Q3 Revenue, Reaffirms 2026 Outlook
Revenue rose 7% year over year. The company expects Core EPS to increase by a low double-digit percentage at constant exchange rates.
More news
- TokenPostUSDT0 Freezes 6.18 Million Tokens on Polygon After Binance Hack
- TokenPostIntel Shares Fall 27% Before Open on Weak Fourth-Quarter Outlook
- crypto.newsCertiK to provide security tools and mentorship to Web3 startups through Arbitrum program
- TokenPostKioxia Forecasts Third-Quarter Operating Profit Below Market Estimate
- TokenPostCZ Says Binance's $2 Billion Hack Gap Is Manageable With SpaceX Stake
- TokenPostHyperliquid Account's 30-Day Loss Hit $7.95 Million as of Oct. 30